← Back to Clinical Trials
Recruiting NCT06631261

NCT06631261 Cardiopulmonary Responses to 6-Minute Stepper Test in Bronchiectasis Versus Healthy Controls

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06631261
Status Recruiting
Phase
Sponsor Hacettepe University
Condition Bronchiectasis Adult
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2024-09-18
Primary Completion 2026-01-18

Trial Parameters

Condition Bronchiectasis Adult
Sponsor Hacettepe University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-09-18
Completion 2026-01-18
Interventions
No intervention; Observational study

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Individuals with bronchiectasis exhibit productive cough and recurrent lung infections as well as reduced exercise capacity, physical activity level, and respiratory and peripheral muscle strength. 6-minute walk test (6MWT) is often used to assess exercise capacity in chronic lung diseases. 6MWT is recommended to be performed along a flat corridor, at least 30 m long, with low pedestrian traffic, on a hard surface. To overcome technical limitations during 6MWT, 6-minute stepper test (6MST) has been proposed to assess exercise capacity. Another test that provides information about exercise capacity is the 1-minute sit-to-stand test (1STS). To our knowledge, there is limited information about different exercise tests including 6MST and 1STS and cardiopulmonary responses to these tests in individuals with bronchiectasis. Therefore, this study aims to compare the responses to the 6MST between individuals with bronchiectasis and healthy controls and to investigate the relationships among 6MST, 6MWT, and 1STS responses and muscle strength.

Eligibility Criteria

Bronchiectasis group - Inclusion criteria for the study: * Being 18 years of age and older, * Having a clinically stable bronchiectasis, * To cooperate with the tests to be performed, * Not having a cardiovascular disease, orthopedic or neurological problem that may affect the tests, * Being willing to participate in the study. Bronchiectasis group - Exclusion criteria: * Being in an acute exacerbation period, * Having a cardiovascular, orthopedic or neurological problem that may affect the tests, * Not being willing to participate in the study. Control group - Inclusion criteria for the study: * Being 18 years of age and older, * To cooperate with the tests to be performed, * Not having a cardiovascular, orthopedic or neurological problem that may affect the tests, * Being willing to participate in the study. Control group - Exclusion criteria: \- Individuals with any known internal disease and those who do not volunteer to participate in the study will not be included in the study.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology